Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer. Darlix A, Hirtz C, Mollevi C, Ginestet N, et al. Int J Cancer 2021 Jul 1. doi: 10.1002/ijc.33724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Darlix A, Hirtz C, Mollevi C, Ginestet N, et al. Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer. Int J Cancer 2021 Jul 1. doi: 10.1002/ijc.33724.
PMID: 34196964